seen from Germany
seen from China
seen from Iraq
seen from United States
seen from United States
seen from United States
seen from Yemen
seen from China
seen from United States
seen from United States
seen from Germany
seen from United States
seen from Malaysia
seen from United States
seen from United States
seen from United States
seen from Malaysia
seen from United States
seen from Slovenia
seen from Slovenia
Cipla share price: Buy Cipla, target price Rs 668: ICICI Securities
[ad_1]
ICICI Securities has given a buy rating to Cipla with a revised target price of Rs 668 (earlier Rs 542) based on 23 times FY22E earnings.
Cipla has received the final USFDA approval for generic Proventil HFA Inhalation Aerosol (albuterol sulfate inhalation aerosol). This approval was expected in the second half of FY21 and the early approval has surprised positively. Cipla’s albuterol is…
View On WordPress
Cipla share price: Buy Cipla, target price Rs 522: Emkay Global
[ad_1]
Emkay Globalhas a buy rating on Cipla with a target price of Rs 522, over a CMP of Rs 513. Cipla has received approval for generic proventil MDI (Albuterol Sulphate 90mcg/inhalation), making it the first generic approval for the product. According to the brokerage, this is a key positive, Currently, albuterol has three brands – Proair, Proventil and Ventolin – and six players across these…
View On WordPress
Cadila Healthcare share price: Share market update: Pharma shares advance; Cadila Healthcare jumps 15%
[ad_1]
NEW DELHI: Pharma shares were trading with gains in Wednesday’s session with their sectoral index trading higher.
Shares of Cadila Healthcare (up 15.18 per cent), Alkem Laboratories (up 13.59 per cent), Torrent Pharmaceuticals (up 7.21 per cent), Divis Laboratories (up 5.52 per cent), Cipla (up 5.11 per cent), Sun Pharmaceutical Industries (up 4.92 per cent), Dr Reddys Laboratories (up…
View On WordPress
Cadila Healthcare share price: Share market update: Pharma shares advance; Cadila Healthcare jumps 15%
[ad_1]
NEW DELHI: Pharma shares were trading with gains in Wednesday’s session with their sectoral index trading higher.
Shares of Cadila Healthcare (up 15.18 per cent), Alkem Laboratories (up 13.59 per cent), Torrent Pharmaceuticals (up 7.21 per cent), Divis Laboratories (up 5.52 per cent), Cipla (up 5.11 per cent), Sun Pharmaceutical Industries (up 4.92 per cent), Dr Reddys Laboratories (up…
View On WordPress
